Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol

INTRODUCTION: The emergence of antibiotic-resistant bacteria has driven renewed interest in older antibacterials, including colistin. Previous studies have shown that colistin is less effective and more toxic than modern antibiotics. In vitro synergy studies and clinical observational studies sugges...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:BMJ Open
Huvudupphovsmän: Dickstein, Yaakov, Leibovici, Leonard, Yahav, Dafna, Eliakim-Raz, Noa, Daikos, George L, Skiada, Anna, Antoniadou, Anastasia, Carmeli, Yehuda, Nutman, Amir, Levi, Inbar, Adler, Amos, Durante-Mangoni, Emanuele, Andini, Roberto, Cavezza, Giusi, Mouton, Johan W, Wijma, Rixt A, Theuretzbacher, Ursula, Friberg, Lena E, Kristoffersson, Anders N, Zusman, Oren, Koppel, Fidi, Dishon Benattar, Yael, Altunin, Sergey, Paul, Mical
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMJ Publishing Group 2016
Ämnen:
Infectious Diseases
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4838684/
https://ncbi.nlm.nih.gov/pubmed/27098822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2015-009956
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk